Research progress on ureteral stent crusts

doi:10.3877/cma.j.issn.1674-3253.2024.04.017

Abstract

Abstract:

As a common device in Urology, ureteral stents can effectively dilate the ureter, promote the smooth flow of urine, and help to relieve ureteral obstruction. However, the use of ureteral stents may also cause a series of side effects and complications, the most common of which is stent crusting. This phenomenon can easily lead to stent brittleness or even fracture, and increase the risk of ureteral avulsion during extubation. At the same time, the formation of sediment may also hinder urine drainage and cause damage to the ureter. This article reviews the mechanism, risk factors and related research progress of ureteral stent crusting.

Key words: Ureteral stents, Crust, Biological film, Bacterial colonization, Coating, Polyurethane, Degradable material

Daocheng Fang, Lixin Chen, Yuanyuan Hu. Research progress on ureteral stent crusts[J]. Chinese Journal of Endourology(Electronic Edition), 2024, 18(04): 402-405.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhqjmnmwkzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-3253.2024.04.017

https://zhqjmnmwkzz.cma-cmc.com.cn/EN/Y2024/V18/I04/402

References 48

[1]	Mosayyebi A, Vijayakumar A, Yue QY, et al. Engineering solutions to ureteral stents: material, coating and design[J]. Cent European J Urol, 2017, 70(3): 270-274.
[2]	Zhao J, Cao Z, Ren L, et al. A novel ureteral stent material with antibacterial and reducing encrustation properties[J]. Mater Sci Eng C Mater Biol Appl, 2016, 68: 221-228.
[3]	何朝辉, 王航涛, 唐福才, 等. 长期留置输尿管内支架对肾功能的影响[J]. 广州医科大学学报, 2017, 45(1): 32-35.
[4]	覃斌, 吴清国, 季汉初, 等. 上尿路双J管长期滞留合并结石治疗方法的选择[J]. 中国微创外科杂志, 2018, 18(8): 767-768.
[5]	林长明, 侯冰冰, 古宏兵, 等. 遗忘双J管自然断裂2例[J]. 临床泌尿外科杂志, 2019, 34(4): 332-333.
[6]	Khoddami S, Chew BH, Lange D. Problems and solutions of stent biofilm and encrustations: a review of literature[J]. Turk J Urol, 2020, 46(Supp. 1): S11-S18.
[7]	Small AC, Thorogood SL, Shah O, et al. Emerging mobile platforms to aid in stone management[J]. Urol Clin North Am, 2019, 46(2): 287-301.
[8]	Cao Z, Zhao J, Yang K. Cu-bearing stainless steel reduces cytotoxicity and crystals adhesion after ureteral epithelial cells exposing to calcium oxalate monohydrate[J]. Sci Rep, 2018, 8(1): 14094.
[9]	Lange D, Bidnur S, Hoag N, et al. Ureteral stent-associated complications-where we are and where we are going[J]. Nat Rev Urol, 2015, 12(1): 17-25.
[10]	Bai F, Cai Z, Yang L. Recent progress in experimental and human disease-associated multi-species biofilms[J]. Comput Struct Biotechnol J, 2019, 17: 1234-1244.
[11]	Yu Tsukanov A, Akhmetov DS, Blesman AI, et al. The impact of ureteral stent surface on encrustation and biofilm formation[J]. Urologiia, 2018(2): 40-45.
[12]	Roy R, Tiwari M, Donelli G, et al. Strategies for combating bacterial biofilms: a focus on anti-biofilm agents and their mechanisms of action[J]. Virulence, 2018, 9(1): 522-554.
[13]	de Grazia A, Somani BK, Soria F, et al. Latest advancements in ureteral stent technology[J]. Transl Androl Urol, 2019, 8(Suppl 4): S436-S441.
[14]	Zumstein V, Betschart P, Albrich WC, et al. Biofilm formation on ureteral stents - incidence, clinical impact, and prevention[J]. Swiss Med Wkly, 2017, 147: w14408.
[15]	Chew BH, Chan J, Choy D, et al. The interaction of urinary components with biomaterials in the urinary tract: ureteral stent discoloration[J]. J Endourol, 2020, 34(5): 608-616.
[16]	Toprak T, Şahin A, Kutluhan MA, et al. Does duration of stenting increase the risk of clinical infection?[J]. di, 2020, 91(4): 237-240.
[17]	Kartal I G, Baylan B, Gok A, et al. The association of encrustation and ureteral stent indwelling time in urolithiasis and KUB grading system[J]. Urol J, 2018, 15(6): 323-328.
[18]	Shabeena KS, Bhargava R, Manzoor MAP, et al. Characteristics of bacterial colonization after indwelling double-J ureteral stents for different time duration[J]. Urol Ann, 2018, 10(1): 71-75.
[19]	Zampini A, Nguyen AH, Rose E, et al. Defining dysbiosis in patients with urolithiasis[J]. Sci Rep, 2019, 9(1): 5425.
[20]	Buhmann MT, Abt D, Nolte O, et al. Encrustations on ureteral stents from patients without urinary tract infection reveal distinct urotypes and a low bacterial load[J]. Microbiome, 2019, 7(1): 60.
[21]	Li X, Gao H, Sun X, et al. A preliminary study on the role of Bacteroides fragilis in stent encrustation[J]. World J Urol, 2021, 39(2): 579-588.
[22]	Beysens M, Tailly TO. Ureteral stents in urolithiasis[J]. Asian J Urol, 2018, 5(4): 274-286.
[23]	Kawahara T, Ito H, Terao H, et al. Ureteral stent encrustation, incrustation, and coloring: morbidity related to indwelling times[J]. J Endourol, 2012, 26(2): 178-182.
[24]	Forbes C, Scotland KB, Lange D, et al. Innovations in ureteral stent technology[J]. Urol Clin North Am, 2019, 46(2): 245-255.
[25]	Rebl H, Renner J, Kram W, et al. Prevention of encrustation on ureteral stents: which surface parameters provide guidance for the development of novel stent materials?[J]. Polymers, 2020, 12(3): 558.
[26]	Cottone CM, Lu S, Wu YX, et al. Surface-treated pellethanes: comparative quantification of encrustation in artificial urine solution[J]. J Endourol, 2020, 34(8): 868-873.
[27]	El-Nahas AR, Lachine M, Elsawy E, et al. A randomized controlled trial comparing antimicrobial (silver sulfadiazine)-coated ureteral stents with non-coated stents[J]. Scand J Urol, 2018, 52(1): 76-80.
[28]	Szell T, Dressler FF, Goelz H, et al. In vitro effects of a novel coating agent on bacterial biofilm development on ureteral stents[J]. J Endourol, 2019, 33(3): 225-231.
[29]	Ahmed EM. Hydrogel: preparation, characterization, and applications: a review[J]. J Adv Res, 2015, 6(2): 105-121.
[30]	Singha P, Locklin J, Handa H. A review of the recent advances in antimicrobial coatings for urinary catheters[J]. Acta Biomater, 2017, 50: 20-40.
[31]	Gadzhiev N, Gorelov D, Malkhasyan V, et al. Comparison of silicone versus polyurethane ureteral stents: a prospective controlled study[J]. BMC Urol, 2020, 20(1): 10.
[32]	Tian Q, Zhang C, Deo M, et al. Responses of human urothelial cells to magnesium-zinc-strontium alloys and associated insoluble degradation products for urological stent applications[J]. Mater Sci Eng C Mater Biol Appl, 2019, 96: 248-262.
[33]	Champagne S, Mostaed E, Safizadeh F, et al. In vitro degradation of absorbable zinc alloys in artificial urine[J]. Materials, 2019, 12(2): 295.
[34]	Asakawa J, Iguchi T, Tamada S, et al. Treatment outcomes of ureteral stenting for malignant extrinsic ureteral obstruction: a comparison between polymeric and metallic stents[J]. Cancer Manag Res, 2018, 10: 2977-2982.
[35]	Zhao J, Cao Z, Lin H, et al. In vivo research on Cu-bearing ureteral stent[J]. J Mater Sci Mater Med, 2019, 30(7): 83.
[36]	Barros AA, Oliveira C, Ribeiro AJ, et al. In vivo assessment of a novel biodegradable ureteral stent[J]. World J Urol, 2018, 36(2): 277-283.
[37]	Chew BH, Lange D, Paterson RF, et al. Next generation biodegradable ureteral stent in a yucatan pig model[J]. J Urol, 2010, 183(2): 765-771.
[38]	肖世伟, 李亚楠, 刘军, 等. 可降解输尿管支架管的研究进展[J]. 中华泌尿外科杂志, 2018, 39(1): 76-78.
[39]	Mosayyebi A, Lange D, Yann Yue Q, et al. Reducing deposition of encrustation in ureteric stents by changing the stent architecture: a microfluidic-based investigation[J]. Biomicrofluidics, 2019, 13(1): 014101.
[40]	Novikov AA, Tsukanov AY, Akhmetov DS, et al. Noninvasive ultrasonic sanitation of stents for drainage of the upper urinary tract[J]. Biomed Eng, 2018, 52(3): 173-176.
[41]	Ordonez M, Hwang EC, Borofsky M, et al. Ureteral stent versus no ureteral stent for ureteroscopy in the management of renal and ureteral calculi[J]. Cochrane Database Syst Rev, 2019, 2(2): CD012703.
[42]	Acosta-Miranda AM, Milner J, Turk TMT. The FECal Double-J: a simplified approach in the management of encrusted and retained ureteral stents[J]. J Endourol, 2009, 23(3): 409-415.
[43]	Arenas JL, Shen JK, Keheila M, et al. Kidney, ureter, and bladder (KUB): a novel grading system for encrusted ureteral stents[J]. Urology, 2016, 97: 51-55.
[44]	Wollin DA, Joyce AD, Gupta M, et al. Antibiotic use and the prevention and management of infectious complications in stone disease[J]. World J Urol, 2017, 35(9): 1369-1379.
[45]	Lee JH, Muthukumar T, Kim J, et al. Antibiotic prophylaxis for ureteral stent removal after kidney transplantation[J]. Clin Transplant, 2019, 33(3): e13491.
[46]	Rosado-Canto R, Parra-Avila I, Tejeda-Maldonado J, et al. Perioperative fosfomycin disodium prophylaxis against urinary tract infection in renal transplant recipients: a randomized clinical trial[J]. Nephrol Dial Transplant, 2020, 35(11): 1996-2003.
[47]	Alenezi NA, Zanaty F, Hodhod A, et al. The safety of ureteral stenting with the use of potassium citrate for management of renal uric acid stones[J]. Urol Ann, 2020, 12(1): 37-41.
[48]	周腾春, 耿志勇, 陈广进. 双J管拔除困难常见原因分析[J]. 临床和实验医学杂志, 2012, 11(4): 297-298.

Please choose a citation manager

Content to export